Alicia R. Knapp - 08 May 2025 Form 4 Insider Report for Kraft Heinz Co (KHC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 May 2025, 17:43:16 UTC
Prior SEC filing
06 May 2024
Next SEC filing
30 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Heidi Miller, by Power of Attorney

Key filing fact

Alicia R. Knapp filed Form 4 for Kraft Heinz Co (KHC) on 12 May 2025.

Key facts

  • This page summarizes Alicia R. Knapp's Form 4 filing for Kraft Heinz Co (KHC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 12 May 2025, 17:43.

Change

  • Previous filing in this sequence was filed on 06 May 2024.
  • Current net transaction value: +$185,014.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001926822 Primary reporting owner

Knapp Alicia R

Relationship
Director
Address
C/O THE KRAFT HEINZ COMPANY, ONE PPG PLACE, SUITE 3200, PITTSBURGH
Signature
/s/ Heidi Miller, by Power of Attorney
Signature date
12 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KHC transaction

Common Stock

Award

Transaction value
$185,014
Shares
+6,494
Change %
+54%
Price
$28.49
Shares after
18,474
Date
08 May 2025
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Grant of deferred shares, receipt of which is deferred until the six-month anniversary of Ms. Knapp's separation from service as a director.

Footnote F2

Includes an additional 581 shares acquired through a dividend reinvestment program.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .